News
ICU Medical, Investor Conferences
Digest more
TipRanks on MSN6d
Piper Sandler bullish on ICU Medical, initiates with an Overweight
As previously reported, Piper Sandler analyst Jason Bednar initiated coverage of ICU Medical (ICUI) with an Overweight rating and $145 price target The infusion pump market faced regulatory and ...
ICU Medical has recalled two lots of potassium chloride intravenous bags, citing a labeling problem that could lead users to overdose on the IV solution, according to an FDA notice posted Friday.
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended June 30, 2025.
TipRanks on MSN7d
ICU Medical CEO buys $2.47M in common stock
In a regulatory filing, ICU Medical (ICUI) disclosed that its CEO Vivek Jain bought 21.9K shares of common stock on August 14th in a total ...
The mislabeled Potassium Chloride Inj. 20 mEq bags contain an overwrap label with Lot# 1023172 (NDC# 0990-7074-26) and an expiration date of 01-31-2026. ICU Medical is recalling 1 lot of Potassium ...
ICU Medical will release Q1 2025 earnings on May 8, followed by a conference call at 4:30 p.m. ET. ICU Medical, Inc. announced its first quarter 2025 earnings release and conference call ...
ICU Medical Inc., a supplier of infusion therapy-related medical equipment, reported fourth quarter revenue and profit that topped analysts’ expectations. Yet, investors are unhappy, sending the ...
A recall of nearly 62,800 replacement batteries used in ICU Medical infusion pumps has received the FDA’s Class I rating—the agency’s most serious.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care.
Specific lots of the tubes sold under the Bivona brand by ICU's unit Smiths Medical for neonatal or pediatric and adult patients are being recalled due to a manufacturing defect that may cause the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback